MedTrace Logo

Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients

NCT06071065 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2025-01-31

No results posted yet for this study

Summary

The purpose of this research study is to evaluate the impact of clinical pharmacist interventions on treatment outcomes, health-related quality of life (HRQoL),and medication adherence among chronic kidney disease patients.

Pharmacist's intervention aim to answer:

1. How a clinical pharmacist intervention program impact medication adherence in chronic kidney disease?
2. To assess how patients' counseling and medication adherence impact patient health-related quality of life?
3. How a clinical pharmacist intervention program improves clinical outcomes of chronic kidney disease patients?

Conditions

Interventions

BEHAVIORAL

Pharmacist counselling

Counselling session with Pharmacist about disease and medication therapy.

Sponsors & Collaborators

  • Hamdard University

    lead OTHER

Principal Investigators

  • Matti Ullah, PhD · Hamdard University Islamabad Campus

  • Iqra Sagheer · Akbar Niazi Teaching Hospital

  • Muhammad Masoom Akhter, PhD · Hamdard University Islamabad Campus

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-22
Primary Completion
2024-03-20
Completion
2024-05-20

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06071065 on ClinicalTrials.gov